Effects of glucocorticoids and cyclosporine on IL-2 and IκBα mRNA expression in human peripheral blood mononuclear cells

Journal of Clinical Pharmacology

Volumn 39, Issue 2, 1999, Pages 119-124

  Briggs, William A ^a   Han, Su Hua ^a   Miyakawa, Horoshi ^a   Burdick, James F ^a   Kwon, H Moo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; MESSENGER RNA; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MONONUCLEAR CELL;

CELLS, CULTURED; CYCLOSPORINE; DNA-BINDING PROTEINS; GLUCOCORTICOIDS; HUMANS; I-KAPPA B PROTEINS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; RNA, MESSENGER;

EID: 0032938581     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912709922007651     Document Type: Article

References (20)

1. Briggs WA, Gao ZH, Gimenez LF, Scheel PJ, Choi MJ, Burdick JF: Lymphocyte responsiveness to glucocorticoids, cyclosporine, or both. J Clin Pharmacol 1996;36:707-714.
2. Briggs WA, Gao ZH, Scheel PJ, Burdick JF, Gimenez LF, Choi MJ: Differential glucocorticoid responsiveness of dialysis patients' lymphocytes. Perit Dial Int 1996;16:406-411.
3. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-286.
4. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: inhibition of NF-KB activity through induction of IKB synthesis. Science 1995;270:286-290.
5. Ayanlar-Batuman O, Ferrero AP, Diaz A, Jimenez SA: Regulation of transforming growth factor-β1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 1991;88:1574-1580.
6. Khanna A, Li B, Stenzel KH, Suthanthiran M: Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor β-dependent mechanism of inhibition of cell growth. Transplantation 1994;57:577-582.
7. Wilson AG, deVries N, Pociot F, diGiovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor α promotor region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993;171:557-560.
8. Hutchinson IV: Immune mechanisms of long-term graft acceptance. Adv Nephrol Necker Hosp 1996;25:17-38.
9. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri M: A promoter polymorphism of tumor necrosis factor α associated with systemic lupus erythematosus in African-Americans. Arthritis & Rheumatism 1997;40(12):2207-2211.
10. Granelli-Piperno A, Nolan P, Inaba K, Steinman RM: The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promotor. J Exp Med 1990;172:1869-1872.
11. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA: FK-506 and cyclosporine-sensitive activation of the interleukin 2 promotor by calcineurin. Nature 1992;357:692-694.
12. Boumpas DT, Anastassiou ED, Older SA, Tsokos GC, Nelson DL, Balow JE: Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 1991;87:1739-1747.
13. Paliogianni F, Boumpas DT: Glucocorticoids regulate calcineurindependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytes. Transplantation 1995;59:1333-1339.
14. Bauerle PA, Henkel T: Function and activation of NFKB in the immune system. Ann Rev Immunol 1994;12:141-179.
15. Barnes PJ, Karin M: Nuclear factor-KB a pivotal transcription factor in chronic inflammatory diseases. N Eng J Med 1997;336:1066-1071.
16. Beg AA, Baldwin AS: The IKB proteins: multifunctional regulators of Rel/NFKB transcription factors. Genes & Dev 1993;7:2064-2070.
17. Emmel EA, Verweij CL, Durand DB, Higgins KM, Lacy E, Crabtree GR: Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 1989;246:1617-1620.
18. Mattilla PS, Ullman KS, Fiering S, Emmel EA, McCutcheon M, Crabtree GR, Herzenberg LA: The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J 1990;9:4425-4433.
19. Franz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O'Keefe SJ, O'Neill EA: Calcineurin acts in synergy with PMA to inactivate IKB/MAD3, an inhibitor of NFKB. EMBO J 1994;13:861-870.
20. 2+-dependent signal transduction pathways. J Immunol 1995;155:4685-4691.